Slovakia will halt its rollout of AstraZeneca’s Covid-19 vaccine for individuals being given their first doses, its Well being Ministry has stated, after an inquiry into the dying of an individual who suffered blood clots after receiving the jab.
The dying of a 47-year-old girl was seemingly related to her receiving the Anglo-Swedish vaccine, resulting from a medical predisposition she had for blood clotting issues, the nation’s regulator, the State Institute for Drug Management (SUKL) stated final week.
“At present, people who find themselves ready for the second dose … are [still] being vaccinated with the AstraZeneca vaccine,” Well being Ministry spokesperson Zuzana Eliasova stated on Tuesday.
She added that the ministry was contemplating a number of alternate options for its ongoing Covid-19 vaccination marketing campaign, with the subsequent steps to be introduced later this week.
SUKL stated final week that an post-mortem had discovered that the girl had suffered cerebral venous sinus thrombosis – blood clotting stopping blood draining from the mind.
An affiliation between her vaccination and the blood clots was thought of “seemingly” due to her “genetic predisposition to a thrombophilic state,” the institute defined in a press release.
Quite a lot of different European nations have additionally reported instances of blood clots in individuals given AstraZeneca’s Covid-19 vaccine, leading to its use being suspended or restricted to sure age teams.
The European Medicines Company has stated that “uncommon blood clots with low blood platelets must be listed as very uncommon unwanted side effects of Vaxzevria,” however, total, the jab’s advantages outweigh the dangers.